Sanofi SA (NASDAQ:GCVRZ)

0.5752
Delayed Data
As of 10:55am ET
 +0.0252 / +4.58%
Today’s Change
0.15
Today|||52-Week Range
0.59
+19.83%
Year-to-Date
Alnylam Focuses on Pipeline Development Amid Competition
11:02am / Zacks.com - Paid Partner Content
J&J's Ponesimod Superior to Aubagio in Relapsing MS Patients
Sep 12 / Zacks.com - Paid Partner Content
Alnylam Begins Phase III Study on Onpattro for New Indication
Sep 17 / Zacks.com - Paid Partner Content
Lexicon (LXRX) Settles With Sanofi for $260M, Shares Rally
Sep 11 / Zacks.com - Paid Partner Content
Abbott Partners With Sanofi to Upgrade Diabetes Management
Sep 17 / Zacks.com - Paid Partner Content
Should Value Investors Buy Sanofi (SNY) Stock?
Sep 09 / Zacks.com - Paid Partner Content
Aimmune's Peanut Allergy Drug Gets FDA Committee's Support
Sep 16 / Zacks.com - Paid Partner Content
Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?
Sep 05 / MotleyFool.com - Paid Partner Content
Glaxo's Asthma Drug Nucala Gets FDA Nod for Pediatric Use
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.55
Today’s open0.53
Day’s range0.53 - 0.58
Volume10,959
Average volume (3 months)140,271
Market cap--
Data as of 10:55am ET, 09/19/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
--
Industry
--
No executives to display
Corporate headquarters
--, --

Forecasts